ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,794Medicare Part D Prescriptions Filled, Including Refills

Rank: 76 out of 917

$381K Total Retail Price of All Prescriptions

Rank: 227 out of 917

452 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
17% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 452 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

19% of this provider’s 452 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 9,898 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$35 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
AMLODIPINE BESYLATE 536 501 1 5
LISINOPRIL 505 454 2 1
SIMVASTATIN 470 431 3 2
OMEPRAZOLE 446 409 4 4
HYDROCHLOROTHIAZIDE 413 383 5 9
HYDROCODONE-ACETAMINOPHEN 363 307 S3 6 6
LEVOTHYROXINE SODIUM 315 296 7 3
WARFARIN SODIUM 298 291 8 10
CITALOPRAM HBR 280 246 9 15
FUROSEMIDE 242 236 10 7
LOSARTAN POTASSIUM 237 232 11 13
LOVASTATIN 234 227 12 19
METFORMIN HCL 218 200 13 8
GABAPENTIN 206 184 14 17
POTASSIUM CHLORIDE 205 191 15 16
METOPROLOL TARTRATE 201 189 16 11
ATENOLOL 190 174 17 12
TAMSULOSIN HCL 172 172 18 25
ZOLPIDEM TARTRATE 169 146 19 21
BENAZEPRIL HCL 165 158 20 80
ALLOPURINOL 132 131 21 31
FINASTERIDE 119 119 22 77
GLIPIZIDE 110 99 23 40
CARVEDILOL 105 105 24 33
DOXAZOSIN MESYLATE 99 99 25 74
DIGOXIN 99 99 25 41
SERTRALINE HCL 95 83 27 24
DICLOFENAC SODIUM 89 87 28 117
FLUTICASONE PROPIONATE 88 76 29 26
METOPROLOL SUCCINATE 87 81 30 18
TRAMADOL HCL 87 83 30 28
TRAZODONE HCL 86 70 32 22
ALENDRONATE SODIUM 85 85 33 23
CARBIDOPA-LEVODOPA 80 80 34 86
ATORVASTATIN CALCIUM 75 71 35 14
PROAIR HFA 73 63 36 35
PRAVASTATIN SODIUM 68 64 37 20
PREDNISONE 66 57 38 34
PANTOPRAZOLE SODIUM 66 66 38 44
OXYCODONE-ACETAMINOPHEN 65 65 S2 40 46
METHOCARBAMOL 63 52 R 41 87
TRIAMCINOLONE ACETONIDE 62 60 42 96
RISPERIDONE 62 62 42 51
PROPRANOLOL HCL 58 54 44 126
AZITHROMYCIN 54 46 45 61
RANITIDINE HCL 53 41 46 29
CYCLOBENZAPRINE HCL 51 42 R 47 65
ADVAIR DISKUS 51 48 47 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.